1. Home
  2. OCGN vs ZUMZ Comparison

OCGN vs ZUMZ Comparison

Compare OCGN & ZUMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • ZUMZ
  • Stock Information
  • Founded
  • OCGN 2013
  • ZUMZ 1978
  • Country
  • OCGN United States
  • ZUMZ United States
  • Employees
  • OCGN N/A
  • ZUMZ N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • ZUMZ Clothing/Shoe/Accessory Stores
  • Sector
  • OCGN Health Care
  • ZUMZ Consumer Discretionary
  • Exchange
  • OCGN Nasdaq
  • ZUMZ Nasdaq
  • Market Cap
  • OCGN 321.7M
  • ZUMZ 328.7M
  • IPO Year
  • OCGN N/A
  • ZUMZ 2005
  • Fundamental
  • Price
  • OCGN $1.52
  • ZUMZ $22.50
  • Analyst Decision
  • OCGN Strong Buy
  • ZUMZ Hold
  • Analyst Count
  • OCGN 2
  • ZUMZ 1
  • Target Price
  • OCGN $7.00
  • ZUMZ $18.00
  • AVG Volume (30 Days)
  • OCGN 5.9M
  • ZUMZ 215.6K
  • Earning Date
  • OCGN 11-05-2025
  • ZUMZ 12-04-2025
  • Dividend Yield
  • OCGN N/A
  • ZUMZ N/A
  • EPS Growth
  • OCGN N/A
  • ZUMZ N/A
  • EPS
  • OCGN N/A
  • ZUMZ 0.03
  • Revenue
  • OCGN $4,754,000.00
  • ZUMZ $900,253,000.00
  • Revenue This Year
  • OCGN N/A
  • ZUMZ $5.50
  • Revenue Next Year
  • OCGN N/A
  • ZUMZ $1.36
  • P/E Ratio
  • OCGN N/A
  • ZUMZ $689.20
  • Revenue Growth
  • OCGN N/A
  • ZUMZ 1.64
  • 52 Week Low
  • OCGN $0.52
  • ZUMZ $11.31
  • 52 Week High
  • OCGN $1.90
  • ZUMZ $24.37
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 48.14
  • ZUMZ 68.99
  • Support Level
  • OCGN $1.47
  • ZUMZ $21.98
  • Resistance Level
  • OCGN $1.65
  • ZUMZ $23.39
  • Average True Range (ATR)
  • OCGN 0.11
  • ZUMZ 0.80
  • MACD
  • OCGN -0.03
  • ZUMZ 0.15
  • Stochastic Oscillator
  • OCGN 13.51
  • ZUMZ 84.26

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About ZUMZ Zumiez Inc.

Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

Share on Social Networks: